Developer docs
API playgroundTry for free, no card

Search company profiles

Versant Diagnostics

Full company profile

uuid000aoaq

Namestring
Versant Diagnostics
Legal namestring
Versant Diagnostics
Websiteurl
versantdx.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Versant Diagnostics is a privately held, PE-backed physician services company focused on digital anatomic pathology. Founded in October 2021 through a partnership between Alliance Pathology Consultants, healthcare entrepreneurs Jim Billington and Brian Carr, and healthcare private equity firm Iron Path Capital, the company operates as a roll-up/acquisition platform that acquires and partners with independent pathology practices across the United States. It targets hospital systems and physician practices, providing capital infusion, operational support, and digital pathology infrastructure while preserving physician leadership at acquired practices.

The company's core technical asset is the deployment of HALO AP, an AI-powered digital pathology platform from Indica Labs, hosted on Amazon Web Services (AWS) and integrated with LIS/LIMS systems. Versant complements this with Aperio GT 450 DX scanners from Leica Biosystems for whole-slide imaging. The platform enables primary diagnosis, remote pathologist collaboration, second-opinion workflows, consultations, and clinical trial management, and is positioned as AI-agnostic, allowing flexible deployment of third-party AI tools. The company markets compliance with HIPAA, FDA 21 CFR Part 11, and GDPR. Versant operates regional divisions (Midwest, MidAtlantic, Northeast, Northwest, Southeast) and a dedicated dermatopathology sub-brand, Versant DermPath.

Versant's revenue model is professional services: it bills hospitals and physician practices for anatomic pathology diagnostic services delivered through its owned and partnered laboratory network. Go-to-market is sales-led enterprise field sales targeting hospital systems and specialty physician practices, with marketing concentrated on the company website, LinkedIn, press releases distributed via wire services, and participation in industry conferences such as Pathology Visions and dermatology society meetings. Capital for the acquisition strategy is provided by Iron Path Capital, with more than $100 million in growth capital deployed since founding. The network spans seven states (Illinois, Ohio, North Carolina, Virginia, Maine, Washington, Georgia) with pathologists licensed in 42 states.

Short descriptiontext

Versant Diagnostics is a PE-backed physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology services. It serves hospitals, health systems, and physician practices across the U.S. using the HALO AP digital pathology platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGrapevine, United States
HQ citystring
Grapevine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
anatomic pathology services, digital pathology platform, dermatopathology diagnostics, physician services company, surgical pathology services
Industry3 codes
PRIMARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAI
Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Anatomic Pathology Diagnostic Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pathology Diagnostic Services
TypeProfessional Services
Description

Versant Diagnostics generates revenue by providing digital anatomic pathology diagnostic services to hospitals and physician practices through its network of acquired and partnered pathology groups. Revenue comes from professional pathology services billed to healthcare providers and payers.

versantdx.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Versant DermPath
Description

Dermatopathology-focused entity providing definitive skin specimen diagnoses by board-certified dermatopathologists with digital pathology capabilities.

versantdx.com
Core offering1 text field

Versant Diagnostics is a physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology diagnostic services to hospitals and physician practices. The company provides subspecialty pathology expertise across dermatopathology, gastroenterology, urology, hematology, and women's health, supported by the HALO AP AI-powered digital pathology platform from Indica Labs and Aperio GT 450 DX scanners from Leica Biosystems, enabling remote collaboration, primary diagnosis, and consultation across a network of laboratories in seven states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Digital pathology reduces diagnostic turnaround time and enables faster treatment initiation for patients
Product overview1 text field

Versant Diagnostics is an independent physician services company that has built a platform-plus-network model for digital anatomic pathology. The core offering consists of the Versant Diagnostics platform providing capital, technology, and operational support to partner pathology practices, with Versant DermPath serving as the specialized dermatopathology sub-brand. The company deploys HALO AP® from Indica Labs as its primary digital pathology technology across a network of regional divisions (Midwest, MidAtlantic, Northeast, Northwest, Southeast). The platform enables pathologists to transition from conventional glass-slide microscopy to digital workflows, facilitating remote collaboration, consultations, and AI-powered diagnostic evaluation.

Product and service5 records
1Digital Anatomic Pathology Diagnostic Services
CategoryAnatomic Pathology Services
Description

Comprehensive digital anatomic pathology diagnostic services provided to hospitals and physician practices across dermatology, gastroenterology, urology, hematology, and women's health, delivered through a network of regional pathology groups with support from the HALO AP AI-powered digital pathology platform.

2Versant DermPath
CategoryDermatopathology Services
Description

Specialized dermatopathology services providing definitive skin specimen diagnoses by board-certified dermatopathologists using digital pathology capabilities, coordinated across a nationwide network of dermatopathology practices.

3Surgical Pathology and Histology Services
CategorySurgical Pathology Services
Description

Surgical pathology, histology, and immunohistochemistry services delivered to hospitals and physician offices through partner pathology groups, supporting diagnosis of tissue specimens for patient care.

4Molecular Diagnostics and Cytology Services
CategoryAdvanced Diagnostic Services
Description

Cytology, flow cytometry, and molecular diagnostics services provided to hospitals and physician offices for advanced diagnostic evaluation of patient specimens.

5Subspecialty Pathology Consultations
CategoryPathology Consultation Services
Description

Subspecialty pathology consultations and second opinion services enabled by the HALO AP digital pathology platform, allowing referring providers to access board-certified subspecialty experts across dermatopathology, GI pathology, urology, hematopathology, and women's health regardless of geographic location.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1SouthEastern Pathology
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-23
Description

Versant Diagnostics partnered with SouthEastern Pathology, a CAP accredited provider based in Rome, Georgia, extending the network into Georgia and neighboring states. SouthEastern Pathology has been a trusted provider for over 50 years. Dr. Frederick K. Swiger Jr. and Dr. Christopher Kligora continue in their current roles.

versantdx.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-02-04
Description

Versant Diagnostics selected Indica Labs' HALO AP AI-powered digital pathology platform to deploy across its network of laboratories. The platform is hosted on AWS cloud and enables primary diagnosis, consultations, and AI integration. HALO AP is CE-IVDR marked for in-vitro diagnostic use in Europe.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-02-04
Description

Versant Diagnostics selected Aperio GT 450 DX scanners from Leica Biosystems for high-quality digital slide scanning. The scanners are part of the digital pathology deployment alongside HALO AP from Indica Labs.

Strategic tierSupportingTypeTechnology or IntegrationAnnounced on2025-02-04
Description

Versant Diagnostics uses Amazon Web Services (AWS) to host its HALO AP cloud deployment, fully managed by AWS certified HALO experts of Indica Labs' Cloud Services team.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-23
Description

Versant Diagnostics partnered with Avero Diagnostics (formerly Northwest Pathology), based in Bellingham, Washington, to expand into the Pacific Northwest. Dr. Ryan Fortna serves as Regional Managing Director. Avero has been delivering innovative diagnostic solutions for decades and serves hospitals and clinics in the Pacific Northwest.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-23
Description

Versant Diagnostics partnered with Dahl-Chase, based in Bangor, Maine, to expand into the Northeast. Dahl-Chase serves hospitals and physician offices with surgical pathology, histology, immunohistochemistry, cytology, flow cytometry, and molecular diagnostics services. Founded in 1971, Dahl-Chase has over 50 years of diagnostic history with 15 board-certified pathologists.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-05-30
Description

Versant Diagnostics partnered with PRW Laboratories, a distinguished dermatopathology laboratory based in Charlottesville, Virginia, to expand dermatopathology services. This partnership builds out Versant's nationwide network of pathology specialties. Dr. David Rowe serves as Medical Director of PRW Laboratories.

8In-Office Pathology, LLC (IOP)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-10
Description

Versant Diagnostics and IOP entered a joint collaboration agreement to increase access to pathologists and build pathology labs nationwide. Versant will offer pathology services to IOP's network of in-office labs, and IOP will build laboratories at select Versant specialty clinics and physician practices. IOP has over 90 high complexity testing installations in 30 states.

versantdx.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Independent anatomic pathology services company offering subspecialty pathology across dermatopathology, GI, urology, and women's health. Directly comparable to Versant in customer base, service mix, and digital pathology focus; CEO Jim Billington previously co-founded Inform DX.

TypeDirect peer
Description

Specialty oncology-focused clinical laboratory and anatomic pathology services provider with national reach. Comparable in business model (specialty pathology services to hospitals and physicians), scale, and digital pathology adoption via acquisition-led growth.

TypeBroad incumbent
Description

Largest independent clinical and anatomic pathology laboratory in the U.S. Provides diagnostic testing services across the full range of pathology, including anatomic pathology for hospitals and physicians. A broad incumbent against which Versant competes for hospital and physician referrals.

TypeBroad incumbent
Description

Major clinical and anatomic pathology services provider with a national laboratory network. Several Versant senior executives previously held leadership roles at LabCorp, indicating direct familiarity with the competitor's go-to-market.

TypeBroad incumbent
Description

Global medical diagnostics company with significant anatomic pathology operations in the U.S. (former Aurora Diagnostics network). Operates a multi-specialty anatomic pathology platform comparable to Versant's roll-up model.

TypeBroad incumbent
Description

National reference and anatomic pathology laboratory affiliated with the University of Utah, offering highly subspecialized pathology services to hospitals and health systems. Comparable in subspecialty expertise and complex case mix.

TypeEmerging player
Description

AI-powered pathology technology company deploying machine learning tools for diagnostic and biopharma applications. Competes with Versant on the digital pathology software layer and may eventually partner with or disintermediate traditional pathology services providers.

TypeEmerging player
Description

Digital pathology software company offering enterprise imaging and AI-ready platforms for pathology labs. Comparable to the HALO AP deployment at Versant and represents an alternative technology vendor for similar roll-up strategies.

TypeEmerging player
Description

AI-based pathology company with clinically deployed cancer detection algorithms. Represents a competitive threat to traditional pathology services in dermatopathology and other high-volume specialties, potentially eroding Versant's subspecialty value proposition.

TypeDirect peer
Description

Specialty molecular pathology and precision medicine company offering advanced anatomic and molecular diagnostics to hospitals and physicians. Versant's CIO Doug Olson previously served as CIO at Caris, indicating direct operational familiarity with the company's model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Versant Diagnostics

Anatomic Pathology Diagnostic Servicesversantdx.com

Versant Diagnostics is a PE-backed physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology services. It serves hospitals, health systems, and physician practices across the U.S. using the HALO AP digital pathology platform.

What Versant Diagnostics does

Versant Diagnostics is a privately held, PE-backed physician services company focused on digital anatomic pathology. Founded in October 2021 through a partnership between Alliance Pathology Consultants, healthcare entrepreneurs Jim Billington and Brian Carr, and healthcare private equity firm Iron Path Capital, the company operates as a roll-up/acquisition platform that acquires and partners with independent pathology practices across the United States. It targets hospital systems and physician practices, providing capital infusion, operational support, and digital pathology infrastructure while preserving physician leadership at acquired practices.

The company's core technical asset is the deployment of HALO AP, an AI-powered digital pathology platform from Indica Labs, hosted on Amazon Web Services (AWS) and integrated with LIS/LIMS systems. Versant complements this with Aperio GT 450 DX scanners from Leica Biosystems for whole-slide imaging. The platform enables primary diagnosis, remote pathologist collaboration, second-opinion workflows, consultations, and clinical trial management, and is positioned as AI-agnostic, allowing flexible deployment of third-party AI tools. The company markets compliance with HIPAA, FDA 21 CFR Part 11, and GDPR. Versant operates regional divisions (Midwest, MidAtlantic, Northeast, Northwest, Southeast) and a dedicated dermatopathology sub-brand, Versant DermPath.

Versant's revenue model is professional services: it bills hospitals and physician practices for anatomic pathology diagnostic services delivered through its owned and partnered laboratory network. Go-to-market is sales-led enterprise field sales targeting hospital systems and specialty physician practices, with marketing concentrated on the company website, LinkedIn, press releases distributed via wire services, and participation in industry conferences such as Pathology Visions and dermatology society meetings. Capital for the acquisition strategy is provided by Iron Path Capital, with more than $100 million in growth capital deployed since founding. The network spans seven states (Illinois, Ohio, North Carolina, Virginia, Maine, Washington, Georgia) with pathologists licensed in 42 states.

Versant Diagnostics firmographics

Firmographics
Name
Versant Diagnostics
Legal name
Versant Diagnostics
Website
https://versantdx.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Versant Diagnostics is a PE-backed physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology services. It serves hospitals, health systems, and physician practices across the U.S. using the HALO AP digital pathology platform.
Ownership category
akta.pro rank

Versant Diagnostics industry classification

Industry
Product category
Anatomic Pathology Diagnostic Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAI
Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Anatomic pathology services
  • Digital pathology platform
  • Dermatopathology diagnostics
  • Physician services company
  • Surgical pathology services

Where Versant Diagnostics is headquartered

Location

Headquarters

HQ city
Grapevine
HQ country
United States
HQ region
North America

Offices9 records

Markets served

Versant Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pathology Diagnostic Services: Versant Diagnostics generates revenue by providing digital anatomic pathology diagnostic services to hospitals and physician practices through its network of acquired and partnered pathology groups. Revenue comes from professional pathology services billed to healthcare providers and payers.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Versant Diagnostics product offering

Product offering

Core offering

Versant Diagnostics is a physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology diagnostic services to hospitals and physician practices. The company provides subspecialty pathology expertise across dermatopathology, gastroenterology, urology, hematology, and women's health, supported by the HALO AP AI-powered digital pathology platform from Indica Labs and Aperio GT 450 DX scanners from Leica Biosystems, enabling remote collaboration, primary diagnosis, and consultation across a network of laboratories in seven states.

Product overview

Versant Diagnostics is an independent physician services company that has built a platform-plus-network model for digital anatomic pathology. The core offering consists of the Versant Diagnostics platform providing capital, technology, and operational support to partner pathology practices, with Versant DermPath serving as the specialized dermatopathology sub-brand. The company deploys HALO AP® from Indica Labs as its primary digital pathology technology across a network of regional divisions (Midwest, MidAtlantic, Northeast, Northwest, Southeast). The platform enables pathologists to transition from conventional glass-slide microscopy to digital workflows, facilitating remote collaboration, consultations, and AI-powered diagnostic evaluation.

Differentiator

Problem solved

Functional benefit

Brands

  • Versant DermPath: Dermatopathology-focused entity providing definitive skin specimen diagnoses by board-certified dermatopathologists with digital pathology capabilities.

Products and services

  • Digital Anatomic Pathology Diagnostic Services Comprehensive digital anatomic pathology diagnostic services provided to hospitals and physician practices across dermatology, gastroenterology, urology, hematology, and women's health, delivered through a network of regional pathology groups with support from the HALO AP AI-powered digital pathology platform.
  • Versant DermPath Specialized dermatopathology services providing definitive skin specimen diagnoses by board-certified dermatopathologists using digital pathology capabilities, coordinated across a nationwide network of dermatopathology practices.
  • Surgical Pathology and Histology Services Surgical pathology, histology, and immunohistochemistry services delivered to hospitals and physician offices through partner pathology groups, supporting diagnosis of tissue specimens for patient care.
  • Molecular Diagnostics and Cytology Services Cytology, flow cytometry, and molecular diagnostics services provided to hospitals and physician offices for advanced diagnostic evaluation of patient specimens.
  • Subspecialty Pathology Consultations Subspecialty pathology consultations and second opinion services enabled by the HALO AP digital pathology platform, allowing referring providers to access board-certified subspecialty experts across dermatopathology, GI pathology, urology, hematopathology, and women's health regardless of geographic location.

Quantifiable outcome

  • Digital pathology reduces diagnostic turnaround time and enables faster treatment initiation for patients

Companies that use Versant Diagnostics

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Versant Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature4 records

Versant Diagnostics partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and supporting.

  • SouthEastern PathologycoreStrategic or Co-development Partner · 23 September 2025Versant Diagnostics partnered with SouthEastern Pathology, a CAP accredited provider based in Rome, Georgia, extending the network into Georgia and neighboring states. SouthEastern Pathology has been a trusted provider for over 50 years. Dr. Frederick K. Swiger Jr. and Dr. Christopher Kligora continue in their current roles.
  • Indica LabscoreTechnology or Integration · 4 February 2025Versant Diagnostics selected Indica Labs' HALO AP AI-powered digital pathology platform to deploy across its network of laboratories. The platform is hosted on AWS cloud and enables primary diagnosis, consultations, and AI integration. HALO AP is CE-IVDR marked for in-vitro diagnostic use in Europe.
  • Leica BiosystemscoreTechnology or Integration · 4 February 2025Versant Diagnostics selected Aperio GT 450 DX scanners from Leica Biosystems for high-quality digital slide scanning. The scanners are part of the digital pathology deployment alongside HALO AP from Indica Labs.
  • Amazon Web Services (AWS)supportingTechnology or Integration · 4 February 2025Versant Diagnostics uses Amazon Web Services (AWS) to host its HALO AP cloud deployment, fully managed by AWS certified HALO experts of Indica Labs' Cloud Services team.
  • Avero DiagnosticscoreStrategic or Co-development Partner · 23 December 2024Versant Diagnostics partnered with Avero Diagnostics (formerly Northwest Pathology), based in Bellingham, Washington, to expand into the Pacific Northwest. Dr. Ryan Fortna serves as Regional Managing Director. Avero has been delivering innovative diagnostic solutions for decades and serves hospitals and clinics in the Pacific Northwest.
  • Dahl-Chase Pathology Associates and Dahl-Chase Diagnostic ServicescoreStrategic or Co-development Partner · 23 October 2023Versant Diagnostics partnered with Dahl-Chase, based in Bangor, Maine, to expand into the Northeast. Dahl-Chase serves hospitals and physician offices with surgical pathology, histology, immunohistochemistry, cytology, flow cytometry, and molecular diagnostics services. Founded in 1971, Dahl-Chase has over 50 years of diagnostic history with 15 board-certified pathologists.
  • PRW LaboratoriescoreStrategic or Co-development Partner · 30 May 2023Versant Diagnostics partnered with PRW Laboratories, a distinguished dermatopathology laboratory based in Charlottesville, Virginia, to expand dermatopathology services. This partnership builds out Versant's nationwide network of pathology specialties. Dr. David Rowe serves as Medical Director of PRW Laboratories.
  • In-Office Pathology, LLC (IOP)coreStrategic or Co-development Partner · 10 April 2023Versant Diagnostics and IOP entered a joint collaboration agreement to increase access to pathologists and build pathology labs nationwide. Versant will offer pathology services to IOP's network of in-office labs, and IOP will build laboratories at select Versant specialty clinics and physician practices. IOP has over 90 high complexity testing installations in 30 states.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Versant Diagnostics competitors and assessment

Company assessment

Direct peers

  • Inform Diagnostics: Independent anatomic pathology services company offering subspecialty pathology across dermatopathology, GI, urology, and women's health. Directly comparable to Versant in customer base, service mix, and digital pathology focus; CEO Jim Billington previously co-founded Inform DX.
  • NeoGenomics: Specialty oncology-focused clinical laboratory and anatomic pathology services provider with national reach. Comparable in business model (specialty pathology services to hospitals and physicians), scale, and digital pathology adoption via acquisition-led growth.
  • Caris Life Sciences: Specialty molecular pathology and precision medicine company offering advanced anatomic and molecular diagnostics to hospitals and physicians. Versant's CIO Doug Olson previously served as CIO at Caris, indicating direct operational familiarity with the company's model.

Broad incumbents

  • Quest Diagnostics: Largest independent clinical and anatomic pathology laboratory in the U.S. Provides diagnostic testing services across the full range of pathology, including anatomic pathology for hospitals and physicians. A broad incumbent against which Versant competes for hospital and physician referrals.
  • Labcorp: Major clinical and anatomic pathology services provider with a national laboratory network. Several Versant senior executives previously held leadership roles at LabCorp, indicating direct familiarity with the competitor's go-to-market.
  • Sonic Healthcare: Global medical diagnostics company with significant anatomic pathology operations in the U.S. (former Aurora Diagnostics network). Operates a multi-specialty anatomic pathology platform comparable to Versant's roll-up model.
  • ARUP Laboratories: National reference and anatomic pathology laboratory affiliated with the University of Utah, offering highly subspecialized pathology services to hospitals and health systems. Comparable in subspecialty expertise and complex case mix.

Emerging players

  • PathAI: AI-powered pathology technology company deploying machine learning tools for diagnostic and biopharma applications. Competes with Versant on the digital pathology software layer and may eventually partner with or disintermediate traditional pathology services providers.
  • Proscia: Digital pathology software company offering enterprise imaging and AI-ready platforms for pathology labs. Comparable to the HALO AP deployment at Versant and represents an alternative technology vendor for similar roll-up strategies.
  • Ibex Medical Analytics: AI-based pathology company with clinically deployed cancer detection algorithms. Represents a competitive threat to traditional pathology services in dermatopathology and other high-volume specialties, potentially eroding Versant's subspecialty value proposition.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Versant Diagnostics social profiles

Digital presence

Versant Diagnostics compliance and trust

Trust signal

Compliance4 records

Versant Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Versant Diagnostics leadership team

Management profile

Number of profiles

Profiles15 records

Versant Diagnostics subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Versant Diagnostics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Versant Diagnostics M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Versant Diagnostics

What does Versant Diagnostics do?

Versant Diagnostics is a physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology diagnostic services to hospitals and physician practices. The company provides subspecialty pathology expertise across dermatopathology, gastroenterology, urology, hematology, and women's health, supported by the HALO AP AI-powered digital pathology platform from Indica Labs and Aperio GT 450 DX scanners from Leica Biosystems, enabling remote collaboration, primary diagnosis, and consultation across a network of laboratories in seven states.

Is Versant Diagnostics a public or private company?

Versant Diagnostics is a private company. It is classified as private equity controlled and is currently operating.

When was Versant Diagnostics founded?

Versant Diagnostics was founded in 2021. It employs 11 to 50 people.

Where is Versant Diagnostics based?

Versant Diagnostics is headquartered in Grapevine, United States, in the North America region.

How does Versant Diagnostics make money?

One revenue line is on record: pathology Diagnostic Services.

Who are Versant Diagnostics's main competitors?

Direct peers on record are Inform Diagnostics, NeoGenomics and Caris Life Sciences. Broad incumbents are Quest Diagnostics, Labcorp, Sonic Healthcare and ARUP Laboratories. Emerging players are PathAI, Proscia and Ibex Medical Analytics.

Does Versant Diagnostics have an API?

No public API is recorded for Versant Diagnostics.

What industry is Versant Diagnostics in?

Versant Diagnostics's product category is Anatomic Pathology Diagnostic Services. Its primary akta.pro industry code is HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic), with a secondary code of HLACALAJ, Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ThemiddlemarketIron Path-Backed Versant Diagnostics Purchases ADLVersant Diagnostics, backed by Iron Path Capital, has acquired American Dermatopathology Laboratory, a dermatopathology practice located in Centerville, Ohio. This acquisition enhances Versant DermPath's expertise in dermatopathology and expands Versant Diagnostics' laboratory network to seven states, supported by pathologists licensed in 42 states.Business Wire BlogVersant Diagnostics Acquires American Dermatopathology Laboratory, LLC, and Welcomes Distinguished Dermatopathologist H. Nicholas Shamma, MDVersant Diagnostics, an independent physician services company based in Grapevine, Texas, has acquired American Dermatopathology Laboratory, a dermatopathology practice based in Centerville, Ohio. As part of the strategic expansion, Dr. H. Nicholas Shamma, a nationally recognized dermatopathologist, has joined the company and will serve as a partner within Versant DermPath, the company's dermatopathology-focused entity. With this acquisition, Versant Diagnostics now operates a network of laboratories across seven states with pathologists licensed in 42 states.FinancialContent Business PageVersant Diagnostics Acquires American Dermatopathology Laboratory, LLC, and Welcomes Distinguished Dermatopathologist H. Nicholas Shamma, MDVersant Diagnostics, an independent physician services company, has acquired American Dermatopathology Laboratory, a dermatopathology practice based in Centerville, Ohio, with Dr. H. Nicholas Shamma joining as a nationally recognized dermatopathologist under the Versant DermPath entity. The acquisition expands Versant Diagnostics' network to laboratories across seven states with pathologists licensed in 42 states. Versant is pursuing a robust growth strategy that includes recent expansions into Georgia, the Pacific Northwest, and North Carolina, positioning the company as a national leader in diagnostic medicine.MorningstarVersant Diagnostics Acquires American Dermatopathology Laboratory, LLC, and Welcomes Distinguished Dermatopathologist H. Nicholas Shamma, MDVersant Diagnostics acquired American Dermatopathology Laboratory, a dermatopathology practice in Centerville, Ohio, and appointed H. Nicholas Shamma, MD, as a partner in Versant DermPath. The company now operates labs across seven states with pathologists licensed in 42 states, and is expanding into Georgia and the Pacific Northwest.VersantdxVersant Diagnostics Acquires American Dermatopathology Laboratory, LLC, and Welcomes Distinguished Dermatopathologist H. Nicholas Shamma, M.D.Versant Diagnostics acquired American Dermatopathology Laboratory in Centerville, Ohio, and appointed H. Nicholas Shamma, MD, as a partner in its dermatopathology entity. The company now operates labs across seven states with pathologists licensed in 42 states. It is expanding into Georgia and the Pacific Northwest.Business Wire BlogVersant Diagnostics Expands into Georgia with Partnership with SouthEastern PathologyVersant Diagnostics announced a strategic partnership with SouthEastern Pathology to expand into Georgia, extending its digital anatomic pathology network. The partnership aims to make digitally-enabled pathology services more accessible and aligns with Versant's vision to become the largest digital anatomic pathology company in the U.S.GlobeNewswireVersant Diagnostics Partners with Avero Diagnostics to Refocus Regional Pathology Services in the Pacific NorthwestVersant Diagnostics announced an affiliation with Avero Diagnostics, a Bellingham, Washington-based anatomic pathology provider, to expand its Pacific Northwest presence. Ryan Fortna, M.D., Ph.D., will serve as Regional Managing Director. The partnership aims to strengthen physician and patient access to Versant's nationwide network of pathology specialists.YahooVersant Diagnostics Partners with Avero Diagnostics to Refocus Regional Pathology Services in the Pacific NorthwestVersant Diagnostics announced a partnership with Avero Diagnostics, a Bellingham, Washington-based anatomic pathology provider, to expand its Pacific Northwest presence. Ryan Fortna, M.D., Ph.D., will serve as Regional Managing Director. The collaboration aims to strengthen physician and patient access to Versant's nationwide network of specialists.GlobeNewswireVersant Diagnostics Partners with Avero Diagnostics to Refocus Regional Pathology Services in the Pacific NorthwestVersant Diagnostics announced an affiliation with Avero Diagnostics, a Bellingham, Washington-based anatomic pathology provider, to expand its Pacific Northwest presence. Ryan Fortna, M.D., Ph.D., will serve as Regional Managing Director. The partnership aims to strengthen physician and patient access to Versant's nationwide network of pathology specialists.GlobeNewswireVersant Diagnostics Advances Dermatopathology with Acquisition of Cutaneous Pathology, P.A. PracticeVersant Diagnostics acquired Cutaneous Pathology, P.A., a dermatopathology practice in Winston-Salem, N.C., and hired Omar P. Sangueza, M.D. as a dermatopathologist. Dr. Sangueza previously trained many fellows and authored publications on dermatopathology. The acquisition expands Versant's network of dermatopathologists.